Health CanadaGeneral Alert
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Published: April 28, 2021Recall ID: 62381Category: generalCountry: Canada
Safety AlertHealth CanadaCanada
CanadaBamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Recalling Firm: Marketed health products
Reason for Recall / Hazard
COVID - Product safety
Product Description & Identification
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Additional Source Details
| Field | Value |
|---|---|
| N I D | 62381 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/bamlanivimab-potential-risk-treatment-failure-due-circulation-resistant-sars-cov-2 |
| Issue | COVID - Product safety |
| Title | Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2021-04-28 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants Check if your household is affected: https://therecallfile.com/recalls/bamlanivimab-potential-risk-of-treatment-failure-due-to-circulation-of/CANADA-62381
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Featured on Product Hunt
Help support our public safety mission and check out our community launch.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordBamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Related Recalls
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018088 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018088 -
Tires
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018288 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018288 -
Airbag
—TC
Safety AlertHealth Canada
Health CanadaTransport Canada Recall - 2018409 -
TC
Health CanadaGeneral Alert
Transport Canada Recall - 2018409 -
Airbag
—TC